Heart rate variability, exercise capacity and levels of daily physical activity in children and adolescents with mild-to-moderate cystic fibrosis

Pitiguara de Freitas Coelho; Roberta Ribeiro Batista Barbosa; Rodrigo Dos Santos Lugao; Fernanda Mayrink Gonçalves Liberato; Pâmela Reis Vidal; Roberta de Cássia Nunes Cruz Melotti; Márcio Vinícius Fagundes Donadio

doi:10.1142/S1013702522500019

Heart rate variability, exercise capacity and levels of daily physical activity in children and adolescents with mild-to-moderate cystic fibrosis

Hong Kong Physiother J. 2022 Jun;42(1):5-14. doi: 10.1142/S1013702522500019. Epub 2021 Jun 11.

Authors

Pitiguara de Freitas Coelho¹, Roberta Ribeiro Batista Barbosa¹, Rodrigo Dos Santos Lugao¹, Fernanda Mayrink Gonçalves Liberato², Pâmela Reis Vidal¹, Roberta de Cássia Nunes Cruz Melotti², Márcio Vinícius Fagundes Donadio^{3

4}

Affiliations

¹ Escola Superior de Ciˆencias da Santa Casa de Misericórdia de Vitória - EMESCAM, Vitória, Espírito Santo, Brazil.
² Cystic Fibrosis Reference Center, Hospital Infantil Nossa Senhora da Glória, Vitória, Espírito Santo, Brazil.
³ Laboratory of Pediatric Physical Activity, Centro Infant, Pontifícia Universidade Católica, do Rio Grande do Sul (PUCRS), Porto Alegre, Rio Grande do Sul, Brazil.
⁴ mdonadio@pucrs.br.

Abstract

Background: Autonomic nervous system balance is altered in cystic fibrosis (CF), although its influence on physical fitness has been poorly explored.

Objective: This study aimed to evaluate the association of heart rate variability (HRV) with exercise capacity and levels of daily physical activity in children and adolescents with mild-to-moderate CF.

Methods: A cross-sectional study including individuals with CF aged 6-18 years, not under CFTR modulator therapy, was performed. Sociodemographic (age, sex) and clinical information (airway colonization, pancreatic insufficiency, and genotyping) were collected. In addition, exercise capacity (modified shuttle test - MST), lung function (spirometry), body composition (bioimpedance), levels of daily physical activity (5-day accelerometer), and HRV (both at rest and during the MST) were evaluated.

Results: 30 individuals (20 females) aged $11.2 \pm 3.7$ years, mean FEV $_{1} 62.8 \pm 27.6$ %, were included. A sympathovagal balance (LF/HF) increase ( $p < 0.001$ ) during the MST was shown, indicating a predominance of sympathetic modulation. The standard deviation of all RR intervals (SDNN) and the high frequency (HF) index during exercise correlated significantly with FEV₁ ( $r = 0.45$ , $p = 0.01$ and $r = 0.46$ , $p = 0.01$ ; respectively). MST distance also correlated positively and significantly with SDNN ( $r = 0.43$ , $p = 0.01$ ), square root of the mean of the sums of squares of frequencies between RR intervals greater than 50 ms - RMSSD ( $r = 0.53$ , $p < 0.01$ ), low frequency - LF ( $r = 0.48$ , $p < 0.01$ ), HF ( $r = 0.64$ , $p < 0.01$ ), dispersion of points perpendicular to the short-term identity line - SD1 ( $r = 0.40$ , $p = 0.02$ ) and negatively with LF/HF ( $r =- 0.57$ , $p < 0.01$ ). Regarding daily physical activity, SDNN at rest ( $r = 0.37$ , $p = 0.04$ ) and exercise ( $r = 0.41$ , $p = 0.02$ ) showed positive correlations with time in moderate-to-vigorous activities. When normalizing the SDNN and classifying individuals as normal or altered, those presenting altered SDNN showed poorest FEV₁ ( $p = 0.001$ ) and lower exercise capacity ( $p = 0.027$ ).

Conclusion: HRV correlates with lung function, exercise capacity and levels of daily physical activity in children and adolescents with CF. The study highlights the influence of CF on autonomic function and suggests HRV measurement as an easy tool to be used in clinical settings as an alternative marker to monitor CF individuals.

Keywords: Cystic fibrosis; exercise capacity; heart rate variability; modified shuttle test; pediatrics.